1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Dahiyat, B.I.
Mayo, S.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
Science
SCIEAS
0038
0036-8075
278
82
87
10.1126/science.278.5335.82
9311930
De novo protein design: fully automated sequence selection.
1997
10.2210/pdb1fsd/pdb
pdb_00001fsd
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
3497.037
FULL SEQUENCE DESIGN 1 OF BETA BETA ALPHA MOTIF
1
man
polymer
no
no
QQYTAKIKGRTFRNEKELRDFIEKFKGR
QQYTAKIKGRTFRNEKELRDFIEKFKGR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
32630
synthetic construct
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-11-12
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1997-06-09
REL
REL
NO RESTRAINT VIOLATIONS GREATER THAN 0.3 ANGSTROMS
100
41
NOESY
DQF-COSY
TOCSY
5.0
280
K
STANDARD X-PLOR REFINEMENT PROTOCOLS WERE USED WITH A FINAL REPEL RADIUS OF 0.8.
HYBRID DISTANCE GEOMETRY-SIMULATED ANNEALING
BRUNGER
refinement
X-PLOR
3.1
structure solution
X-PLOR
600
Varian
UNITYPLUS
GLN
1
n
1
GLN
1
A
GLN
2
n
2
GLN
2
A
TYR
3
n
3
TYR
3
A
THR
4
n
4
THR
4
A
ALA
5
n
5
ALA
5
A
LYS
6
n
6
LYS
6
A
ILE
7
n
7
ILE
7
A
LYS
8
n
8
LYS
8
A
GLY
9
n
9
GLY
9
A
ARG
10
n
10
ARG
10
A
THR
11
n
11
THR
11
A
PHE
12
n
12
PHE
12
A
ARG
13
n
13
ARG
13
A
ASN
14
n
14
ASN
14
A
GLU
15
n
15
GLU
15
A
LYS
16
n
16
LYS
16
A
GLU
17
n
17
GLU
17
A
LEU
18
n
18
LEU
18
A
ARG
19
n
19
ARG
19
A
ASP
20
n
20
ASP
20
A
PHE
21
n
21
PHE
21
A
ILE
22
n
22
ILE
22
A
GLU
23
n
23
GLU
23
A
LYS
24
n
24
LYS
24
A
PHE
25
n
25
PHE
25
A
LYS
26
n
26
LYS
26
A
GLY
27
n
27
GLY
27
A
ARG
28
n
28
ARG
28
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
27
A
A
OD1
H
ASN
GLU
14
17
1.60
1
A
GLN
2
-65.31
-79.47
1
A
ALA
5
-61.86
80.40
1
A
ILE
7
-51.76
-94.66
2
A
GLN
2
-174.54
96.92
2
A
ALA
5
-58.36
88.46
2
A
ILE
7
-52.26
-93.56
2
A
LYS
26
-90.72
58.43
3
A
GLN
2
-174.66
96.51
3
A
ALA
5
-62.53
81.04
3
A
ILE
7
-47.05
-95.41
4
A
GLN
2
-174.34
94.79
4
A
ALA
5
-62.35
83.61
4
A
ILE
7
-50.97
-93.59
4
A
PHE
25
-140.40
40.20
4
A
LYS
26
-91.18
57.68
5
A
GLN
2
-76.97
-81.15
5
A
ALA
5
-47.79
96.56
5
A
ILE
7
-52.92
-94.97
5
A
PHE
25
-97.72
-76.61
5
A
LYS
26
174.81
-35.88
6
A
GLN
2
-76.96
-80.96
6
A
ALA
5
-59.71
87.38
6
A
LYS
6
-92.27
55.85
6
A
ILE
7
-48.64
-93.77
6
A
PHE
25
-123.16
-86.21
7
A
GLN
2
-102.04
-87.26
7
A
ALA
5
-60.21
86.04
7
A
ILE
7
-106.78
-77.43
7
A
ARG
10
-151.46
89.53
8
A
GLN
2
-110.61
-79.86
8
A
ALA
5
-59.81
87.35
8
A
ILE
7
-54.83
-89.98
8
A
PHE
25
-98.72
30.53
9
A
GLN
2
-178.80
100.69
9
A
ALA
5
-58.05
87.90
9
A
ILE
7
-54.05
-87.71
9
A
PHE
21
-90.60
-60.37
9
A
PHE
25
-102.51
-76.60
9
A
LYS
26
176.94
-36.59
10
A
GLN
2
-175.08
96.01
10
A
ALA
5
-49.84
92.90
10
A
LYS
6
-98.53
47.86
10
A
ILE
7
-42.41
-95.23
10
A
ARG
10
-160.22
110.15
11
A
GLN
2
-80.26
-88.68
11
A
LYS
6
-116.26
64.19
11
A
ILE
7
-50.55
-93.44
12
A
GLN
2
-116.96
-82.67
12
A
ALA
5
-62.17
81.78
12
A
ILE
7
-50.50
-88.19
13
A
GLN
2
-177.00
101.47
13
A
ALA
5
-59.28
92.03
13
A
LYS
6
-67.82
90.95
13
A
ILE
7
-57.62
-81.27
13
A
ARG
10
-165.22
98.48
14
A
GLN
2
-94.41
-85.28
14
A
ALA
5
-45.91
94.73
14
A
ILE
7
-48.45
-94.60
15
A
GLN
2
-126.83
-82.78
15
A
ALA
5
-51.67
176.74
15
A
ILE
7
-51.00
-93.08
16
A
GLN
2
-135.32
-80.79
16
A
ALA
5
-58.06
96.90
16
A
PHE
25
-141.02
39.55
16
A
LYS
26
-91.83
57.61
17
A
GLN
2
-103.29
-79.26
17
A
ALA
5
-66.83
72.96
17
A
LYS
6
-67.45
84.58
17
A
ILE
7
-51.08
-91.53
17
A
PHE
25
-133.67
-83.66
18
A
GLN
2
-94.45
-80.48
18
A
ALA
5
-58.27
177.66
18
A
ILE
7
-54.97
-80.25
19
A
GLN
2
-97.28
-79.10
19
A
ALA
5
-59.31
86.77
19
A
ILE
7
-48.35
-92.55
20
A
GLN
2
-122.44
-88.49
20
A
ALA
5
-45.61
93.90
20
A
LYS
6
-95.98
53.75
20
A
ILE
7
-44.45
-95.10
21
A
GLN
2
-110.67
-84.83
21
A
LYS
6
-111.81
78.11
21
A
ILE
7
-51.49
-86.65
22
A
GLN
2
-125.02
-65.36
22
A
ALA
5
-58.95
89.78
22
A
ILE
7
-57.06
-82.50
23
A
GLN
2
-178.31
99.34
23
A
ALA
5
-49.73
92.99
23
A
LYS
6
-97.93
48.37
23
A
ILE
7
-42.10
-94.41
24
A
GLN
2
-79.30
-84.52
24
A
ALA
5
-49.30
106.44
24
A
ILE
7
-52.23
-95.68
24
A
ARG
10
-173.46
139.90
25
A
GLN
2
-126.00
-81.12
25
A
ALA
5
-57.33
96.07
25
A
ILE
7
-117.35
-80.71
25
A
PHE
25
-127.28
-84.62
26
A
ALA
5
-65.44
75.03
26
A
ILE
7
-46.68
-94.36
27
A
GLN
2
-133.86
-100.05
27
A
ALA
5
-46.08
94.75
27
A
LYS
6
-96.31
55.13
27
A
ILE
7
-44.18
-95.64
28
A
GLN
2
-120.36
-84.40
28
A
ALA
5
-56.61
90.32
28
A
ILE
7
-53.75
-97.06
29
A
GLN
2
-125.25
-101.48
29
A
ALA
5
-54.19
92.92
29
A
ILE
7
-50.40
-93.51
30
A
GLN
2
61.00
97.16
30
A
ALA
5
-59.21
88.22
30
A
ILE
7
-50.68
-94.11
31
A
GLN
2
-86.63
-86.78
31
A
ILE
7
-53.48
-98.22
32
A
GLN
2
-88.33
-79.46
32
A
ALA
5
-61.28
86.69
32
A
ILE
7
-57.87
-90.72
33
A
GLN
2
60.74
96.82
33
A
ALA
5
-57.57
88.96
33
A
ILE
7
-51.31
-96.37
34
A
GLN
2
-61.27
-81.06
34
A
ALA
5
-61.83
85.97
34
A
ILE
7
-53.35
-88.94
34
A
LYS
26
-90.88
58.21
35
A
GLN
2
-127.71
-92.48
35
A
ALA
5
-49.05
173.46
35
A
LYS
6
-150.87
61.01
35
A
ILE
7
-51.57
-94.34
35
A
PHE
25
-133.38
-84.41
36
A
GLN
2
-69.51
-85.63
36
A
ALA
5
-52.76
109.36
36
A
ILE
7
-49.66
-93.87
37
A
GLN
2
-104.56
-88.98
37
A
ILE
7
-51.73
-94.30
38
A
GLN
2
-64.94
-80.09
38
A
ALA
5
-64.08
77.26
38
A
ILE
7
-47.39
-93.23
39
A
GLN
2
60.42
94.69
39
A
TYR
3
-108.13
48.73
39
A
ALA
5
-53.24
92.96
39
A
ILE
7
-55.09
-96.78
39
A
ARG
10
-166.44
84.62
39
A
PHE
25
-99.04
-76.19
39
A
LYS
26
178.60
-36.53
40
A
GLN
2
-106.45
-82.01
40
A
ALA
5
-46.97
93.72
40
A
ILE
7
-48.35
-89.51
41
A
GLN
2
-103.09
-79.60
41
A
ALA
5
-57.66
90.26
41
A
ILE
7
-49.17
-94.62
41
A
LYS
26
-92.33
58.06
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
FULL SEQUENCE DESIGN 1 (FSD-1) OF BETA BETA ALPHA MOTIF, NMR, 41 STRUCTURES
1
Y
N
A
GLU
15
A
GLU
15
HELX_P
A
PHE
25
A
PHE
25
1
1
11
hydrog
A
ASN
14
A
OD1
ASN
14
1_555
A
GLU
17
A
N
GLU
17
1_555
NOVEL SEQUENCE
NOVEL SEQUENCE, COMPUTATIONAL DESIGN
1FSD
PDB
1
1FSD
1
28
1FSD
1
28
1FSD
A
1
1
28
1
P 1